Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Dow
Mallinckrodt
US Army
Moodys
Harvard Business School
QuintilesIMS
Fish and Richardson
McKinsey

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 081215

« Back to Dashboard

NDA 081215 describes ESTROPIPATE, which is a drug marketed by Barr, Duramed Pharms Barr, Mylan, Watson Labs, and Watson Labs Teva, and is included in seven NDAs. It is available from three suppliers. Additional details are available on the ESTROPIPATE profile page.

The generic ingredient in ESTROPIPATE is estropipate. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the estropipate profile page.
Summary for 081215
Tradename:ESTROPIPATE
Applicant:Watson Labs Teva
Ingredient:estropipate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 081215
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ESTROPIPATE estropipate TABLET;ORAL 081215 ANDA Actavis Pharma, Inc. 0591-0416 N 0591-0416-01
ESTROPIPATE estropipate TABLET;ORAL 081215 ANDA Actavis Pharma, Inc. 0591-0416 N 0591-0416-05

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength3MG
Approval Date:Sep 23, 1993TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Johnson and Johnson
Covington
Federal Trade Commission
QuintilesIMS
Harvard Business School
Chinese Patent Office
Cipla
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.